CH378885A - Verfahren zur Herstellung von Abkömmlingen der Salicylsäure - Google Patents
Verfahren zur Herstellung von Abkömmlingen der SalicylsäureInfo
- Publication number
- CH378885A CH378885A CH650260A CH650260A CH378885A CH 378885 A CH378885 A CH 378885A CH 650260 A CH650260 A CH 650260A CH 650260 A CH650260 A CH 650260A CH 378885 A CH378885 A CH 378885A
- Authority
- CH
- Switzerland
- Prior art keywords
- dioxodihydro
- sep
- salicylic acid
- compound
- production
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 6
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 title claims description 5
- 238000004519 manufacturing process Methods 0.000 title description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 title 1
- 229960004889 salicylic acid Drugs 0.000 title 1
- WXCAPCKMUGBFSN-UHFFFAOYSA-N 4a,5-dihydro-1,3-benzoxazine-2,4-dione Chemical class C1C=CC=C2OC(=O)NC(=O)C21 WXCAPCKMUGBFSN-UHFFFAOYSA-N 0.000 claims description 10
- 229910052757 nitrogen Inorganic materials 0.000 claims description 10
- 229910052739 hydrogen Inorganic materials 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 239000004215 Carbon black (E152) Substances 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 229930195733 hydrocarbon Natural products 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 229910052751 metal Chemical class 0.000 claims description 2
- 239000002184 metal Chemical class 0.000 claims description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 20
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 18
- 150000001875 compounds Chemical class 0.000 description 15
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- 239000000203 mixture Substances 0.000 description 8
- 159000000000 sodium salts Chemical class 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000013078 crystal Substances 0.000 description 6
- 235000009518 sodium iodide Nutrition 0.000 description 6
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- SKZKKFZAGNVIMN-UHFFFAOYSA-N Salicilamide Chemical compound NC(=O)C1=CC=CC=C1O SKZKKFZAGNVIMN-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229960000581 salicylamide Drugs 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- ZEDHSSVDQTYBRV-UHFFFAOYSA-N 2-bromo-n,n-dimethylpropanamide Chemical compound CC(Br)C(=O)N(C)C ZEDHSSVDQTYBRV-UHFFFAOYSA-N 0.000 description 1
- YMQRPXBBBOXHNZ-UHFFFAOYSA-N 2-chloro-1-morpholin-4-ylethanone Chemical compound ClCC(=O)N1CCOCC1 YMQRPXBBBOXHNZ-UHFFFAOYSA-N 0.000 description 1
- NSWLMOHUXYULKL-UHFFFAOYSA-N 2-chloro-1-piperidin-1-ylethanone Chemical compound ClCC(=O)N1CCCCC1 NSWLMOHUXYULKL-UHFFFAOYSA-N 0.000 description 1
- CQQUWTMMFMJEFE-UHFFFAOYSA-N 2-chloro-n,n-diethylacetamide Chemical compound CCN(CC)C(=O)CCl CQQUWTMMFMJEFE-UHFFFAOYSA-N 0.000 description 1
- XBPPLECAZBTMMK-UHFFFAOYSA-N 2-chloro-n,n-dimethylacetamide Chemical compound CN(C)C(=O)CCl XBPPLECAZBTMMK-UHFFFAOYSA-N 0.000 description 1
- HOZLOOPIXHWKCI-UHFFFAOYSA-N 2-chloro-n-methylacetamide Chemical compound CNC(=O)CCl HOZLOOPIXHWKCI-UHFFFAOYSA-N 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- -1 alkali metal salt Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- SLUNEGLMXGHOLY-UHFFFAOYSA-N benzene;hexane Chemical compound CCCCCC.C1=CC=CC=C1 SLUNEGLMXGHOLY-UHFFFAOYSA-N 0.000 description 1
- OQNGCCWBHLEQFN-UHFFFAOYSA-N chloroform;hexane Chemical compound ClC(Cl)Cl.CCCCCC OQNGCCWBHLEQFN-UHFFFAOYSA-N 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical class CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
- C07D265/26—Two oxygen atoms, e.g. isatoic anhydride
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2142559 | 1959-07-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
CH378885A true CH378885A (de) | 1964-06-30 |
Family
ID=12054628
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH650260A CH378885A (de) | 1959-07-01 | 1960-06-08 | Verfahren zur Herstellung von Abkömmlingen der Salicylsäure |
Country Status (2)
Country | Link |
---|---|
CH (1) | CH378885A (en(2012)) |
FR (1) | FR52M (en(2012)) |
-
1960
- 1960-06-08 CH CH650260A patent/CH378885A/de unknown
- 1960-07-01 FR FR831740A patent/FR52M/fr not_active Expired
Also Published As
Publication number | Publication date |
---|---|
FR52M (en(2012)) | 1960-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DD148050A5 (de) | Verfahren zur herstellung neuer n-aryl-bzw.benzimidazolione | |
CH378885A (de) | Verfahren zur Herstellung von Abkömmlingen der Salicylsäure | |
DE1101428B (de) | Verfahren zur Herstellung langwirkender Aminobenzolsulfonsaeure-amidderivate | |
CH494218A (de) | Verfahren zur Herstellung von 3-Hydroxyimino-steroiden | |
DE1147583B (de) | Verfahren zur Herstellung von 2, 4-Dioxo-dihydro-1, 3-benzoxazinyl-(3)-essigsaeure-dialkylamiden | |
DE2065698A1 (de) | Verfahren zur herstellung von 2isopropyl-6-methyl-4(3h)-pyrimidon | |
AT226710B (de) | Verfahren zur Herstellung von neuen Dihydrochinoxalonen-(2) und von deren Salzen | |
AT278818B (de) | Verfahren zur Herstellung von neuen N-(Cycloalkyloxy-alkyl)-piperazinderivaten, ihren Salzen und quartären Derivaten | |
AT295499B (de) | Verfahren zur Herstellung neuer N<1>-Acyl-phenylhydrazone bzw. -phenylhydrazine, sowie deren Säureadditionssalze | |
AT211302B (de) | Verfahren zur Herstellung neuer Monoalkylaminopropionyl-toluidide und deren Salze | |
DE1122070C2 (de) | Verfahren zur Herstellung von diuretisch wirksamen Disulfamylanilinverbindungen | |
DE1793731C3 (de) | 5-Chlor-2-(hydroxyamino-acetamino)benzophenon | |
AT233594B (de) | Verfahren zur Herstellung von 0,0-Dimethylthionothiolphosphorylessigsäuremonomethylamid | |
AT237628B (de) | Verfahren zur Herstellung des neuen 3-Phenoxypropylguanidins | |
AT234698B (de) | Verfahren zur Herstellung von 4-Sulfanilamido-2,6-di-nieder-alkoxy-pyrimidinen | |
AT223188B (de) | Verfahren zur Herstellung neuer N,N-disubstituierter Monoaminoalkylamide und ihrer Salze | |
AT309444B (de) | Verfahren zur Herstellung von neuen Thieno[2,3-e][1,4]-diazepin-2-onen sowie von den Säureadditionssalzen hievon | |
AT212331B (de) | Verfahren zur Herstellung von neuen Ferrocenderivaten | |
AT294809B (de) | Verfahren zur Herstellung von neuen p-Aminobenzoesäureaniliden und deren Salzen | |
AT210886B (de) | Verfahren zur Herstellung von neuen, basisch substituierten Diphenylcarbinolestern und deren Salzen | |
AT270619B (de) | Verfahren zur Herstellung von neuen 3,4,5-Trimethoxy-β-aminoacrylophenonen | |
CH269338A (de) | Verfahren zur Herstellung einer neuen Piperidinverbindung. | |
CH509309A (de) | Verfahren zur Herstellung von neuen Thiosemicarbazonen | |
DE2625848A1 (de) | Substituierte 1,2,4-oxadiazolidin-3- on-verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als pflanzenschutzmittel | |
DE2558719B2 (de) | Alpha-geschweifte klammer auf 4- eckige klammer auf 2-(2.4-dichlorbenzoylamino) -aethyl eckige klammer zu -phenoxy geschweifte klammer zu-isobuttersaeure, deren methyl- und aethylester sowie deren pharmakologisch vertraegliche salze und arzneimittel, die diese verbindungen enthalten |